Evaluate the Safety and Tolerability
1 clinical trials · Condition
◉ Watch Evaluate the Safety and Tolerability
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults (NCT07518589) | Shenzhen Kangzhe Biotechnology Co., Ltd. | 2026-04-02 |
Track Evaluate the Safety and Tolerability automatically
Every clearance here is in the API, with alerts when new ones post.